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ABSTRACT
Protein degradation by the ubiquitin-proteasome system in neurons
depends on the correct delivery of the proteasome complex.
In neurodegenerative diseases, aggregation and accumulation of
proteins in axons link transport defects with degradation
impairments; however, the transport properties of proteasomes
remain unknown. Here, using in vivo experiments, we reveal
the fast anterograde transport of assembled and functional 26S
proteasome complexes. A high-resolution tracking system to follow
fluorescent proteasomes revealed three types of motion: actively
driven proteasome axonal transport, diffusive behavior in a
viscoelastic axonema and proteasome-confined motion.
We show that active proteasome transport depends on motor
function because knockdown of the KIF5B motor subunit resulted in
impairment of the anterograde proteasome flux and the density of
segmental velocities. Finally, we reveal that neuronal proteasomes
interact with intracellular membranes and identify the coordinated
transport of fluorescent proteasomes with synaptic precursor
vesicles, Golgi-derived vesicles, lysosomes and mitochondria.
Taken together, our results reveal fast axonal transport as a new
mechanism of proteasome delivery that depends on membrane
cargo ‘hitch-hiking’ and the function of molecular motors. We further
hypothesize that defects in proteasome transport could promote
abnormal protein clearance in neurodegenerative diseases.
KEY WORDS: Axonal transport, Membrane interaction, Molecular
motors, Proteasome, Vesicles, Kinesin-1
INTRODUCTION
Local protein homeostasis in highly polarized neurons is
supported by a regulated system of protein delivery by axonal
transport and a coordinated action of protein removal by selective
degradation (Bingol and Sheng, 2011; Stokin and Goldstein,
2006). The localization of the ubiquitin-proteasome system (UPS)
has emerged as an important regulator of synaptic function,
and local proteasome degradation defects have been implicated
during the progression of many neurodegenerative diseases
(Oddo, 2008; Yi and Ehlers, 2007). However, little is known
about the intracellular mechanisms of the distribution of the
proteasome and their axonal transport properties that assure the
proper delivery and positioning of the proteasome complex in
neurons.
Protein turnover by the UPS involves the identification of
targets and their tagging with a polyubiquitin chain as the signal
for specific degradation by the proteasome complex (Ciechanover
and Brundin, 2003). The 26S proteasome barrel is assembled
through the interaction of the 20S catalytic core, which comprises
four rings of a and b subunits, with the 19S regulatory particle
(Murata et al., 2009). Several synaptic proteins have been
shown to undergo local UPS-mediated turnover, suggesting a
compartment-specific function for the 26S complex (Ehlers,
2003; Patrick, 2006). In response to neuron depolarization,
proteasomes can be rapidly recruited to dendritic spines by a
mechanism that is not fully understood (Bingol and Schuman,
2006; Bingol et al., 2010), leading to a confined turnover of
polyubiquitinated proteins (Djakovic et al., 2009; Ehlers, 2003)
that supports a compartmentalized function of the proteasome at
synapses (Upadhya et al., 2006; Zhao et al., 2003). Proteasome-
mediated degradation is involved in the clearance of abnormal
protein aggregates and proteasome defects have been associated
with a number of neurodegenerative diseases (Ciechanover and
Brundin, 2003). Local dysfunction of proteasome-dependent
degradation is associated with the early phases of synaptic
defects in tauopathies, including the formation of inclusion bodies
that contain the ubiquitinated form of the microtubule-associated
protein tau (Tai et al., 2012).
Axonal transport, carried out by molecular motors, supports
neuronal function by the correct delivery and positioning of
proteins and organelles (Stokin and Goldstein, 2006). Kinesin
motors drive the anterograde axonal transport towards the
synapses by walking the microtubules to the plus end, whereas
dynein complexes support the retrograde transport to cell bodies
by walking to the minus end of microtubules (Hirokawa et al.,
2010). Fast axonal transport is mediated by membrane-associated
cargos that have been described as interacting specifically with
kinesin and dynein motors (Goldstein, 2003; Karki and Holzbaur,
1999). Cytosolic proteins undergo slow axonal transport, which
has also been shown to depend on an interaction with molecular
motors that is mediated by adaptor proteins (Terada et al., 2010).
This slow average speed of soluble proteins depends on a
probabilistic association with carriers that move under fast
transport (Lasek et al., 1984; Scott et al., 2011). In support of
this view, recent data has shown an axonal diffusion, with an
anterograde bias, of synapsin that was mediated by the flux of fast
moving vesicles (Tang et al., 2013). However, little is known
1Instituto de Biologı´a Celular y Neurociencias (UBA-CONICET), Facultad de
Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina.
2Department of Cellular and Molecular Medicine, School of Medicine, University
of California San Diego, La Jolla, CA 92093, USA. 3Departamento de Fı´sica y
IFIBA-CONICET, Facultad de Ciencias Exactas y Naturales, Universidad de
Buenos Aires, Buenos Aires CP 1428, Argentina.
*Present address: Department of Molecular and Experimental Medicine, Dorris
Neuroscience Center, The Scripps Research Institute La Jolla, CA 92037, USA.
`Author for correspondence (tfalzone@fmed.uba.ar)
Received 16 August 2013; Accepted 22 January 2014
 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 1537–1549 doi:10.1242/jcs.140780
1537
Jo
ur
na
l o
f C
el
l S
ci
en
ce
about the transport modes that mediate the movement of large
cytoplasmic protein complexes, such as the proteasome, along
axons. Studies of fluorescently labeled proteasomes have
suggested that, in human fibrosarcoma cells, the distribution of
proteasomes occurs through cytoplasmic diffusion at a steady
state (Reits et al., 1997), whereas in vivo and in vitro analyses
have suggested that proteasomes associate with lipid membranes
(Kalies et al., 2005; Newman et al., 1996), and that this
interaction could support a mechanism for the long-range
movement of proteasomes in neurons.
Disruption of the microtubule-based transport system results in
organelle accumulation and axonal swellings, which can be
further increased by impairments in the protein clearance
pathways (Stokin and Goldstein, 2006). In neurodegenerative
diseases, impaired protein degradation has been suggested to
occur through specific proteasome inhibition that is exerted by
abnormal aggregated proteins (Tai et al., 2012; Tseng et al., 2008)
and by the proteasome defects that have been described in
different areas of the brains of patients with Alzheimer’s disease
(Keck et al., 2003; Keller et al., 2000). Interestingly, failures in
the UPS lead to the accumulation of aggregated proteins in axons
(Tai and Schuman, 2008), and protein accumulation is, in turn,
associated with defects in axonal transport (Stokin and Goldstein,
2006). Thus, the confined accumulation of polyubiquitinated
aggregates that is observed during neurodegeneration raises the
possibility that impairments in the distal axonal delivery of UPS
components play central roles in disease progression (Bence
et al., 2001; Oddo, 2008; Rubinsztein, 2006). Similar abnormal
function of the proteasome can be predicted during impairment
of axonal transport because kinesin-1 defects enhance protein
accumulation, axonopathies and neurodegeneration in mouse
models of Alzheimer’s disease (Falzone et al., 2009; Stokin et al.,
2005). Recently, a link between proteasomes and motors
in mammalian cells has been suggested to occur through the
proteasome-associated protein ECM29, which is involved in
proteasome assembly (Gorbea et al., 2010). This interaction
indicates a molecular mechanism for motor-protein-dependent
transport of the proteasome complex.
Here, using in vivo and live-cell imaging experiments, we test
the novel hypothesis that the proteasome complex is actively
transported along axons. By using short-term mouse sciatic nerve
ligations, we also show fast anterograde transport of the
functional 26S proteasome complex. We developed a high-
resolution time and space live-imaging setup to track and describe
the movement of fluorescent a4 core proteasome subunits in
axons, allowing characterization of three new and independent
modes of proteasome motion – (1) actively driven transport, (2)
diffusion in a viscoelastic axonema and (3) trapped proteasomes
with confined motion. We demonstrate that knockdown of the
KIF5B motor protein results in a reduction of the anterograde
proteasome flux on axons and a decrease in the density of
anterograde segmental velocities, which suggests that proteasome
transport partially depends on kinesin-1 cargos for their delivery
to distant sites. Finally, we show that fast and processive
axonal transport of proteasomes depends on the association of
proteasomes with intracellular membranes, and describe the
coordinated movement of proteasomes with different vesicles and
membrane organelles. Taken together, our results describe three
previously unknown modes of proteasome movement in axons
and, furthermore, uncover a novel mechanism of fast axonal
transport of this large and active complex that is dependent upon
membrane cargo ‘hitch-hiking’ and the function of molecular
motors. Therefore, we suggest that distant neuronal protein
degradation depends on a mechanism of proteasome delivery that,
when impaired, can have profound implications for the clearance
of local proteins, similar to that observed during the progression
of neurodegenerative diseases.
RESULTS
In vivo fast axonal transport of active proteasomes in mouse
sciatic nerves
Local UPS-mediated degradation suggests that there are active
proteasomes at synapses (Bingol and Sheng, 2011; Yi and Ehlers,
2007), but how proteasome components arrive at neuronal termini
is unknown. To test whether neuronal proteasomes are
transported along axons in vivo, we performed staining of
short-term mouse sciatic nerve ligations to analyze representative
components of the complex. The accumulation of proteins at the
proximal or distal side of an obstructed nerve is indicative of
their anterograde or retrograde axonal transport, respectively
(Fig. 1A). After ligation, core (a and b) and regulatory (Mss1,
also known as PSMS2) subunits of the proteasome showed
significant accumulation at the proximal side of the ligation
compared with that in distal or unligated nerves (Fig. 1B,C).
Quantification of the accumulated integrated fluorescent
intensity, normalized to phosphorylated neurofilament staining,
revealed a twofold increase of proteasome subunits in proximal
ligated nerves compared with that in distal ligated nerves
(Fig. 1B,C). As a control for proximal accumulation, nerves
were stained for the transmembrane amyloid precursor
protein (APP), which moves in a net anterograde direction
(supplementary material Fig. S1). To determine further whether
proteasomes accumulate at the proximal side within axons, and
not through induced expression in glia, we examined nerve cross-
sections in ligated and unligated nerves. In unligated nerves, the
core b5 subunit of the proteasome was found in axons and
Schwan cells, as shown by co-staining for phosphorylated
neurofilament (an axonal marker) and the glial marker S100;
however, after ligation, a substantial accumulation of b5 was
observed within axons (Fig. 1D). Similar results were obtained
for the regulatory proteasome subunit Mss1 (Fig. 1E). To exclude
artifacts that can arise from glia-induced expression after nerve
trauma, two ligations were generated along the sciatic nerve.
Double-ligation experiments showed the proximal accumulation
of proteasome subunits only at the node closest to the cell body,
whereas proteasomes did not accumulate proximally to the
second node (Fig. 1H). This result confirms that axonal transport
mediates the increase of proteasome subunits and not the ligature
itself.
To gain insight about the functionality of accumulated
proteasome subunits in axons, we tested for the presence of
protein polyubiquitination as a canonical signal for degradation
after ligation (Bossy-Wetzel et al., 2004). Analysis by western
blotting of ligated nerve homogenates showed a large
accumulation of polyubiquitinated proteins at both proximal and
distal ligated nerves when compared with those from unligated
nerves (Fig. 1F). To determine whether the observed proximal
accumulation of proteasome subunits is associated with an increase
in protein degradation, we measured proteasome activity from
nerve homogenates using a fluorescence assay. Quantification of
the fluorescence released after proteasome-dependent peptide
hydrolysis revealed a significant increase in activity in the
proximal region compared with unligated nerve homogenates
(Fig. 1G). Taken together, these results suggest that proteasomes
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undergo fast axonal transport, and that this movement mediates the
accumulation of functional complexes that are involved in the
degradation of local polyubiquitinated proteins.
Fast and processive proteasome axonal transport in cultured
hippocampal neurons
Cargos transported along axons display unique distributions and
localizations that depend upon the motor molecules and their
dynamic properties. In agreement with previous studies (Mengual
et al., 1996), cultured murine hippocampal neurons showed a
diffuse distribution of the core proteasome subunits in cell bodies
(Fig. 2A), dendrites (Fig. 2B), axons (Fig. 2C) and growth cones
(Fig. 2D). To analyze their distribution and the axonal transport
properties of proteasomes in central neurons, we generated a
vector driving the expression of the mouse proteasome a4 core
subunit (PSMA4) fused to the yellow fluorescent protein (YFP)
Fig. 1. In vivo fast axonal transport of active proteasomes. (A) Proximal (PL), distal (DL) and unligated (UL) sides of the sciatic nerve used in staining and
western blots. (B,C) Confocal images of proximal ligated, distal ligated or unligated mouse sciatic nerves showing a-b or Mss1 proteasome subunits and
phosphorylated neurofilaments (p-NF). Scale bars: 50 mm. Quantification of a-b and Mss1 integrated fluorescent intensity from PL and DL nerves, normalized to
p-NF and taking UL as 1. **P,0.02, Student’s t-test, n54 experiments. (D,E) Cross-sections of UL and PL nerves showing b5 (D) and Mss1 (E) staining in axons
(p-nf) and Schwann cells (S-100). Arrows indicate accumulation of the b5 subunit and Mss1 at the PL in axons. Scale bars: 10 mm. (F) Western blotting of
homogenates from PL, DL and UL nerves showing polyubiquitylated proteins. Synuclein (Syn) was used as a loading control. APP and p-JNK were used as
proximal accumulation controls. (G) Proteasome activity in UL and PL nerve homogenates (40 mg) measured by the release of fluorescence (l380–460) after
peptide hydrolysis using a proteasome probe. **P,0.02, Student’s t-test, n53. (H) Images taken, by using a confocal microscope, of double-node experiments
on mouse sciatic nerves showing the staining of a-b proteasome subunits at locations proximal and distal from the first (I) and second (II) ligation nodes. Note the
accumulation of proteasome subunits only at the PLI side of the nerve.
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under the control of the cytomegalovirus promoter (CMV-a4-
YFP). The incorporation of fluorescently tagged a4 subunits
into assembled proteasome complexes was shown by co-
immunoprecipitation of a4–YFP with endogenous proteasomes
in transfected neuroblastoma (N2a) cells (Fig. 2E). To measure
axonal transport, we identified and selected axonal projections by
analyzing the localization of fluorescently tagged marker proteins
that had been transfected into the cells (Fig. 2F; supplementary
material Fig. S2A); polarized microtubule orientation in axons
was confirmed by expression of the microtubule cap protein EB3
(also known as Mapre3) tagged with red fluorescent protein
(EB3–RFP; supplementary material Fig. S2B,C). Continuous
live-imaging recordings at 125 mseconds (8 frames/second) in
hippocampal neurons that had been transfected with CMV-a4-
YFP allowed the generation of kymographs that revealed a
large amount of heterogeneous proteasome motion (Fig. 2G;
supplementary material Movie 1). Analysis of the kymographs
showed a4–YFP particles that had trajectories that resembled
random motion behavior with no overall movement; however, we
also observed clear processive trajectories that corresponded
to anterograde and retrograde axonal transport of a4–YFP
(Fig. 2H,I). Quantification of the a4–YFP processive puncta
revealed fast anterograde and retrograde average net velocities
that correlate with molecular motor-dependent axonal transport
(Fig. 2H,I).
High spatial- and temporal-resolution analyses identify three
different types of proteasome motion
To analyze further the heterogeneous motion of proteasomes in
the axon and to relate it to different distribution mechanisms, we
developed a high-resolution space- and temporal-tracking system.
We obtained highly detailed kymographs by increasing the
temporal resolution of the live-imaging recording to 20 mseconds
(50 frames/second) in hippocampal neurons that had been
transfected with CMV-a4-YFP (Fig. 3A; supplementary
material Movie 2). Single particles were tracked using an
Fig. 2. Axonal transport of a4–YFP proteasome subunits in axons. (A–D) Images of 10-day-old mature hippocampal neurons that show the distribution of a-
b proteasome subunits (yellow arrows) in cell bodies (A, map2), dendrites (B, map2), axons (C, p-nf) and growth cones (D, a5 subunit plus ubiquitin).
(E) Immunoprecipitation (IP) of the proteasome by using pan-antibody against a-b subunits from control (vector) or N2a cells that had been transfected with
CMV-a4-YFP. Control IPs were performed using nonspecific antibodies. IP eluates were probed using antibodies against YFP (a4–YFP) or the 20S proteasome.
(F) The setup used to record movies of anterograde and retrograde axonal transport in hippocampal neurons. To the right and left are plus- and minus-oriented
microtubules, respectively (see supplementary material Fig. S2). (G) Kymograph of time against distance obtained from a 30-second movie generated at 8
frames/second in an axon transfected with a4–YFP (supplementary material Movie 1). Scale bar: 20 mm. (H) Average proportion of a4–YFP particles moving in
an anterograde (ant), retrograde (ret) or random (ran) direction (left panel) and average net velocities for moving a4–YFP particles (right panel). n530 neurons,
638 particles. (I) Kymographs showing the heterogeneous behavior of moving a4–YFP puncta and examples of clear processive anterograde or retrograde
particles (arrows). Scale bars: 20 mm (A,G,I); 10 mm (B–D).
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algorithm developed to identify the position with a sub-pixel
resolution, and recovered trajectories were then cut into segments
of 100 data points (see Materials and Methods). The mean square
displacement (MSD) was computed for each segment using Eqn
1 and fitted to the empirical expression given by Eqn 2, as
described in Materials and Methods (Fig. 3B). Proteasome
trajectories were then classified as actively driven, diffusive or
confined according to the dependence of the MSD with time
(Fig. 3B). By using 500 MSDs obtained from more than 300
trajectories, we identified 20% of proteasome particles as
having an actively driven trajectory, 56% of particles exhibited
a diffusive-like motion and the remaining 24% of particles
displayed a confined proteasome motion (Fig. 3C).
To investigate further these three different types of proteasome
motion, we first determined the distributions of the segmental
velocities obtained for the actively driven anterograde and
retrograde proteasome trajectories. Each processive trajectory
was further divided into segments, and the mean velocity of the
segment was computed from the slope of the position against time
plot. We obtained a higher proportion of anterograde recovered
segmental velocities compared with retrograde ones (Fig. 3D). A
range of segmental velocities for anterograde and retrograde
proteasomes (Fig. 3E) were measured that are comparable to the
velocities reported for vesicles undergoing kinesin- and dynein-
mediated fast axonal transport (Reis et al., 2012). Diffusive-like
trajectories, characterized by a linear dependence of the
MSD with the time lag, allowed the calculation of a diffusion
coefficient of 0.058460.0056 mm2/second (mean6s.e.m.; Materials
and Methods) that is consistent with the molecular size of a
proteasome complex that diffuses in a viscous axonema (Bohn
et al., 2010; Popov and Poo, 1992). By contrast, confined
proteasome trajectories showed a plateau in the MSD plot
(Fig. 3B), which determines a confinement region of 0.726
0.03 mm in size (Materials and Methods). The density distribution
function obtained from confined single-particle trajectories showed
that the constraint exerted over the proteasome is less than that
exerted by elastic binding trapping (Jin et al., 2007), suggesting
that the movement of a confined proteasome is bound by a ‘cage’
(supplementary material Fig. S3A). Taken together, these results
reveal that there are three different modes of proteasome motion
and, more importantly, describe the processive movement of
particles that display distributions with high segmental velocities
that result from the fast axonal transport of proteasomes.
Knockdown of the kinesin-1 motor impairs fast axonal
transport of the proteasome
To test whether actively driven proteasomes depend on molecular
motor function, we knocked down kif5b, one of the three kinesin-
1 heavy chain subunits that has been shown previously to alter
certain cargos (Encalada et al., 2011), and analyzed proteasome
movement. Efficient knockdown of KIF5B was shown by western
blotting lysates from N2a cells transfected with an shRNA against
kif5b (shKif5b), when compared with control (Fig. 4A,B), and by
immunofluorescent staining of hippocampal neurons (Fig. 4C,D).
To study processive trajectories for a longer period of time,
we acquired movies at 8 frames/second. This rate allowed the
Fig. 3. High-resolution analysis of proteasome
trajectories revealed three patterns of proteasome
movement in axons. (A) Kymograph obtained from a
continuous movie (supplementary material Movie 2) recording
at 20 mseconds/frame (50 frames/second) showing detailed
trajectories of a4–YFP particles. Scale bar: 10 mm. (B) Upper
panel: image crops showing high-magnification kymographs
(100 data point sets) corresponding to proteasome particles
undergoing active transport, random diffusion and confined
motion, respectively. (Arrows indicate particle tracks.) Scale
bars: 2 mm. Lower panel: recovered trajectories from
kymographs shown in the upper panel with their
corresponding mean square displacement (MSD). MSD data
was fitted to an anomalous model MSDta. The corresponding
fittings are shown in red (a52, 1 and 0.4). Insets within each
graph show the recovered trajectories as a function of space
versus time. Horizontal and vertical scale bars in insets
represent 0.5 seconds and 2 mm, respectively. (C) Proportion
of active transport, diffusive movement and confined motion
obtained from 670 particle segments (100 data set points)
generated using 317 single proteasome tracked particles from
87 imaged neurons. Results taken from five transfection
experiments. (D) The proportion of anterograde versus
retrograde segmental velocities. n5259. (E) The distribution
of segmental velocities (%) obtained from proteasome
particles undergoing anterograde and retrograde active
axonal transport.
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recovery of long-range transport of the proteasome from neurons
that had been co-transfected with a4–YFP and shKif5b or a control
shRNA (Fig. 4E; supplementary material Movies 3, 4). Moving
proteasome particles were tracked by using the algorithm, and the
MSDs were calculated for the trajectories of particles in control or
shKif5b-transfected cells to discard segments without active
transport. Hippocampal neurons with reduced levels of KIF5B
exhibited a significant reduction in the proportion of proteasomes
that had anterograde segmental velocities, consequently the
proportion of proteasomes that showed retrograde velocities
increased compared with control (Fig. 4F). Interestingly, this
change in the segmental velocity flux was observed because of a
selective and significant reduction in the density of anterograde
proteasome segments, whereas the average retrograde number was
not significantly impaired (Fig. 4G). We observed a clear change in
the anterograde flux, but the average segmental velocity of
anterograde proteasomes was similar between control and
shKif5b-transfected cells; by contrast, a small increase in the
average retrograde segmental velocities was observed in
cells transfected with shKif5b (Fig. 4H). To test for an interaction
between axonal proteasomes and moving kinesin-1 cargos,
hippocampal neurons that had been transfected with a4–YFP were
stained with an antibody against KIF5B. Imaging of mature
axonal projections, by using confocal microscopy, showed a few
proteasome particles that consistently colocalized with KIF5B
staining (supplementary material Fig. S3B). Taken together, these
results reveal kinesin-1, and in particular KIF5B, as one of the
microtubule-associated molecular motors that contribute to the fast
anterograde axonal transport of the proteasome complex.
Neuronal proteasomes associate with membranes and
fractionate with synaptosome vesicles
Little is known about how the proteasome is shuttled within
neurons; however, we observed proteasome particles moving
with fast and processive velocities that were partially dependent
upon the function of kinesin-1, which is reminiscent of
intracellular-membrane-associated movement. To determine
whether proteasomes are associated with membranes in vivo, we
fractionated mouse brain homogenates by using bottom-loaded
continuous sucrose gradients to identify proteins associated with
membranes. Bona fide soluble proteins (ubiquitin) remained at the
bottom of the gradient, whereas transmembrane proteins [APP,
synaptotagmins and syntaxin 13 (STX12) fractionated at different
densities (Fig. 5A). The soluble and membrane-bound dynein
heavy chain (DYNC1H1) motor showed a wide distribution along
fractions (Fig. 5A). As expected, a proportion of core a5 (PSMA5),
b5 (PSMB5) and regulatory Mss1 proteasome subunits remained in
soluble fractions, whereas a substantial percentage (ranging
from 20% to 30%) separated within fractions 5 to 13, which are
enriched in membrane-associated proteins (Fig. 5B). The similar
fractionation pattern displayed for the different subunits suggests
that proteasomes are tightly assembled and associated with
membranous organelles.
As similar patterns of fractionation were displayed by
proteasome subunits and the synaptic marker synaptotagmin, we
tested whether proteasomes associate with synaptic membranes.
Synaptosomes that had been purified from adult mouse brains
showed the presence of a5 and b5 core proteasome subunits from
the 20S complex in the synaptosome-enriched fraction (LP2)
Fig. 4. Reduction of the KIF5B motor protein impairs
proteasome axonal transport. (A) Western blotting of the KIF5B
protein from N2a cells transfected with a control shRNA (shControl)
or shRNA against kif5b (shKif5b) for 48 hours. Tubulin was used as
a loading control. (B) Integrated optical density (OD) quantification
for normalized KIF5B protein levels in shControl- and shKif5b-
transfected cells from four independent experiments. *P,0.05,
Student’s t-test. (C) Staining with an antibody against KIF5B shows
the level of protein in untransfected (control) hippocampal neuron
(yellow arrow) compared with cells transfected with shKif5b (white
arrow). (D) Integrated intensity (AU, arbitrary units) quantification in
control neurons compared with those transfected with shKif5b.
n510 neurons. *P,0.05, Student’s t-test. (E) Kymographs
generated from 30-second movies (supplementary material Movies
3, 4) showing a4–YFP movement in control (a4–YFP/shControl)
and shKif5b-transfected cells (a4–YFP/shKif5b). Scale bars:
20 mm. (F) The proportion of anterograde versus retrograde
segmental velocities. *P,0.05, Mann–Whitney test, n5268
particles in control cells, 141 particles in shKif5b-transfected cells.
(G) The mean total (Tot.), anterograde (Ant.) and retrograde (Ret.)
density of actively transported proteasomes expressed as seg-
ments in 100 mm of axonal length. **P,0.02, Mann–Whitney test.
(H) Anterograde and retrograde mean segmental velocities for a4–
YFP and shControl, and a4–YFP and shKif5b cells. n55
experiments. Kymographs analyzed n551 segments from control
cells, 45 segments for shKif5b-transfected cells. *P,0.05.
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(Fig. 5C,D). As expected, we also observed enrichment in this
fraction of synaptic transmembrane proteins – synaptotagmin and
synaptophysin (SPH, also known as SYP) – as well as kinesin and
dynein motors (Abe et al., 2009) (Fig. 5C,D). The cytosolic protein
GDP dissociation inhibitor (GDI, also known as GDI1) and free
ubiquitin remained soluble and detected at very low levels in
LP2 (Fig. 5C,D). Interestingly, the Mss1 subunit from the 19S
regulatory particle was present in LP2, whereas the PA28a
(PSME1) subunit from the ubiquitin-independent proteasome was
not (Fig. 5C), suggesting that the 26S complex, which is associated
with polyubiquitin-dependent degradation, is localized to
synaptosomal domains. Taken together, these results indicate that
proteasomes associate with membranes that can mediate their
distribution throughout the neuron.
Proteasome processive particles ‘hitch-hike’ on multiple
membranous organelles for their coordinated fast axonal
transport
To test whether the profile of moving proteasomes depends on the
interaction with one or many subcellular organelles, we acquired
sequential movies that simultaneously monitored fluorescently
tagged a4 proteasome subunits and fluorescent vesicle markers
in neurons. Owing to the presence of proteasome subunits in
synaptosomes, and to test whether proteasomes are co-transported
with synaptic components, we co-transfected cells with vectors
encoding the a4 subunit tagged with mCherry (a4–Cherry) and
synaptophysin fused to GFP (SPH–GFP) (Fig. 6A; supplementary
material Movie 5). Movement of both tagged proteins was
monitored by recording double-color movies, recording sequentially
in the red (a4–Cherry) and then green (SPH–GFP) channel (back
and forth, 15 seconds in each channel). Clearly observable
processive trajectories that were common to both proteasomes
and synaptophysin were identified and quantified, revealing an
association between processive proteasomes and SPH-containing
vesicles (Fig. 6B,I). Because a small percentage of moving
proteasomes were associated with synaptophysin, we tested whether
proteasomes could also associate with other Golgi-derived mem-
branes, such as the APP vesicle (Fig. 6C; supplementary material
Movie 6). Similar to SPH vesicles, APP vesicles that were associated
with moving proteasomes were found to move in both an
anterograde and retrograde direction (Fig. 6D,I). To test further
whether other membranes, such as the endolysosome vesicles,
correlate with proteasome movement, we transfected neurons with
a4–YFP and stained lysosomes with a live-cell tracer (lysotracker-
red, Fig. 6E; supplementary material Movie 7). Interestingly, we
found a higher amount of a4–YFP moving with lysosomes in a
retrograde direction compared with a4–YFP and lysosomes
moving in an anterograde direction (Fig. 6F,I). Finally, proteasome
movement was analyzed together with a mitochondria tracer
(mitotracker-red, Fig. 6G; supplementary material Movie 8), which
showed a4–YFP and mitochondria with common trajectories
(‘shared particles’) in both an anterograde and retrograde direction
(Fig. 6H,I). Controls that were performed prior to movie acquisition
showed no bleed-through of the fluorescent labels in the red or
green channel, confirming that cargos moving within the tested
organelles contain proteasomes (supplementary material Fig. S4A).
Quantification of all proteasome movement events observed in the
sequential double-channel movies revealed that 49% of proteasomes
were associated with lysosome vesicles, synaptophysin-containing
vesicles, APP vesicles or mitochondria (Fig. 6J). Interestingly, 51%
of the processive movement of proteasomes is unaccounted for by
the membrane markers and organelles analyzed here, which suggests
that other organelle compartments are also involved in proteasome
transport (Fig. 6J). Potentially, a high association of a4–YFP
with lysosomes could be interpreted as the protein being
turned over by lysosomes. To exclude this possibility, we treated
Fig. 5. Neuronal proteasomes associate
with membrane and fractionate with
synaptic vesicles. (A) Bottom-loaded
sucrose density fractions of brain
homogenates. The separation of the
proteasome a5, b5 and Mss1 subunits
compared with soluble ubiquitin and
membrane-associated proteins [APP,
synaptotagmin (STG) and syn13]. (B) The
relative protein distribution plotted from the
sucrose density fractionation experiments
normalized to the total protein. Note the
proteasomes in the soluble (1–3) and low-
density (5–13) fractions. (C) Synaptosome
purification from mouse brain cortices loaded
as homogenate (H1), soluble (S1, S2),
plasma membrane (LP1) and synaptosome-
enriched (LP2) fractions. a5, b5, Mss1 and
PA28 subunits of the proteasome. Synaptic
proteins, STG and SPH; molecular motors,
KHC and DHC; and soluble proteins, GDI
and ubiquitin. (D) The proportion of b5, STG
and GDI protein enriched in the LP2 fraction
(blue) compared to other fractions.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 1537–1549 doi:10.1242/jcs.140780
1543
Jo
ur
na
l o
f C
el
l S
ci
en
ce
a4–YFP-transfected N2a cells with the lysosome inhibitor NH4Cl
(50 mM). As expected, full-length APP accumulated after treatment,
but a4–YFP did not (supplementary material Fig. S4B), suggesting
that a4–YFP is not being degraded by lysosomes under these test
conditions. Taken together, these results suggest that actively
transported proteasomes travel along the axon ‘hitch-hiking’ on
multiple intracellular membranes for their delivery to distant
neuronal locations.
DISCUSSION
Dysfunction of the UPS has been implicated in the abnormal
accumulation of proteins that is observed in many
neurodegenerative diseases (Bingol and Sheng, 2011;
Rubinsztein, 2006). Axonal transport by the regulated action of
molecular motors controls synaptic homeostasis through the
delivery of cargo to distant locations (Goldstein, 2003) and by
supporting the local protein clearance pathways. The experiments
presented here constitute the first evidence that a fraction
of neuronal proteasomes undergo fast microtubule- and
motor-dependent transport with dynamics that correspond to
membrane vesicle movement. Moreover, our results reveal three
independent modes of proteasome motion by which proteasomes
are widely distributed throughout neurons.
Cytoskeletal proteins are transported in axons by intracellular
mechanisms, which implies slow component velocities of 1–
10 mm/day (Lasek et al., 1984). The movement of these and
many cytosolic proteins has been suggested to depend on the
interaction with fast motors for their stochastic movement (Scott
et al., 2011). Recently, the fast movement of a carrier, now
identified as moving vesicles, has been suggested to drive the
anterograde slow axonal transport of the synapsin proteins,
suggesting that there are many modes for the movement for
Fig. 6. Neuronal proteasomes
associate with intracellular
membrane organelles for movement.
(A) Images from co-transfected neurons
showing axons containing a4–Cherry
(red) proteasome subunits and
synaptophysin–GFP vesicles (arrows,
SPH–GFP, green). Axons are oriented
with cell bodies to the left and the
synapse to the right. (B) Kymographs
obtained from 45-second (8 Hz) double-
color movies recorded in the red then
green, then red channel (15 seconds
each) corresponding to a4–Cherry (red)
and SPH–GFP (green). Black arrows
correspond to moving particles sharing
the same trajectory (shared particles).
(See supplementary material Movie 5.)
(C,D) Images and kymographs from
double-color movies recorded in similar
conditions to A and B showing the
shared processive movement of a4–
Cherry and APP–YFP vesicles (arrows)
(supplementary material Movie 6).
(E,F) Images and kymographs from
double-color movies recorded in the
green then red, then green channel
showing the shared movement of a4–
YFP (green) and lysosome vesicles
(arrows, lysotracker-red) (supplementary
material Movie 7). (G,H) Images and
kymograph from a double-color movie
recorded in the green then red then
green channel showing the shared
movement of a4–YFP (green) and
mitochondria (arrows, mitotracker-red).
Scale bars: 20 mm. (See supplementary
material Movie 8). (I) Quantification of
shared green and red particles moving in
an anterograde (Ant) or retrograde (Ret)
direction for a4–Cherry with SPH–GFP
(SPH), a4–Cherry with APP–YFP (APP),
a4–YFP with lysotracker (Lyso) and a4–
YFP with mitotracker (Mito). (J) The
proportion of moving proteasomes that
can be independently associated with
synaptic vesicles (SPH), APP,
lysosomes (Lyso) or mitochondria (Mito)
from the total proteasome processive
movement. Note the remaining 51% that
moves associated with unknown cargos.
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soluble proteins (Tang et al., 2013). In this study, we tested
whether the neuronal proteasome complex relies on different
axonal transport mechanisms for movement in axons. Mouse
sciatic nerve ligation experiments showed the accumulation of
core and regulatory proteasome subunits at proximal ligation
sites, indicating fast axonal transport of the 26S degradation
complex in vivo. Moreover, protein polyubiquitination was
increased after ligation, and enhancements in the proteasome
degradation activity were mediated by the specific transport of
the proteasome complex, and were not due to the ligation itself.
These results highlight the relevance of a proteasome delivery
system that, when impaired, can be implicated in the local
ubiquitin-dependent protein accumulation observed after axonal
injury or in pathological dystrophies (Hoopfer et al., 2006).
Previous experiments showing synaptic remodeling mediated
by polyubiquitinated protein tagging and degradation imply a
regulated mechanism of proteasome delivery in neurons (Bingol
et al., 2010; Djakovic et al., 2009; Ehlers, 2003). Through
fluorescent proteasome live-imaging experiments, we described
the axonal motion properties of fluorescently tagged a4
core subunits in neurons of the central nervous system.
Peripheral nerves showed a significant proximal accumulation
of proteasomes with almost no distal accumulation, whereas
central neurons displayed a similar proportion of a4 puncta
moving in a processive manner in both anterograde and
retrograde directions. This initial difference in proteasome
dynamics might be explained by the distinct transport
properties displayed between peripheral and central neurons,
and the methods that suggest long-range accumulation in vivo
during nerve ligation in mice compared with short high-resolution
detection by live imaging in culture. The development of a high-
resolution imaging setup and an accurate tracking system allowed
the identification of at least three modes of proteasome motion in
axons. We described a proportion of processive proteasome
trajectories that display a superdiffusive motion where MSD
dependence arises at values higher than 1.5 (Bruno et al., 2009;
Brunstein et al., 2009; Robert et al., 2012). The range of
velocities observed in this pattern of movement suggests that fast
axonal transport of proteasomes is associated with organelles or
vesicles that are transported by molecular motors. MSD analysis
also revealed a highly represented diffusive behavior for the
proteasome with a diffusion coefficient consistent with the
proteasome molecular size in a medium that is more viscous than
water, such as the axonema (Luby-Phelps, 2000; Popov and Poo,
1992). This important pattern of motion sustains the
homogeneous distribution of proteasomes along the axon;
however, it is insufficient to support the long-range transport of
proteasomes to distant neuronal locations. Confined trajectories
fitted well to a model where the constraint of particles is less than
that exerted by elastic trapping (Jin et al., 2007), suggesting that
this movement is limited in local cages of ,700 nm during the
confined movement pattern. Further analyses are required to
determine the origin of this trapping phenomenon and the linker
that mediates the ‘waiting time’ that proteasomes spend in this
non-transport mode.
In central neurons, fast activity-dependent recruitment of
proteasomes to dendritic spines has been suggested to be a
regulated process that is involved in protein degradation (Bingol
and Schuman, 2006). Recent experiments using yeast two-hybrid
assays and immunoprecipitations in cells have described an
association of proteasomes with the motor machinery that is
mediated by Ecm29 (Gorbea et al., 2010). To test the role of
kinesin-1 in the long-range movement of proteasomes in axons,
we knocked down expression of kif5b using a specific shRNA
(Encalada et al., 2011). The high-accuracy tracking of processive
trajectories allowed the determination of segmental velocities for
actively transported proteasomes. Interestingly, this analysis
yielded detailed information about the selective reduction in the
density of anterograde segmental velocities exerted by kinesin-1
defects, which suggests that the overall transport flux was
impaired, and not the properties of proteasome movement. This
can be explained by a reduction of the number of active kinesins
involved in transport upon treatment with shKif5b but that the
biophysical properties of active kinesins are not affected. The
mean retrograde velocity, which is driven by dynein, is enhanced
in cells treated with shKif5b and can be explained by a recent
report that showed that dyneins work collectively within cells and
that their velocity is sensitive to opposing load (Rai et al., 2013).
KIF5B knockdown showed that proteasome dynamics have a
partial dependency on kinesin-1 and are consistent with the idea
that the 26S proteasome is ‘hitch-hiking’ on different cargos in
order to move. Interestingly, our results fit a model in which
cytosolic proteins are transported by different types of movement
– including the contribution of vesicle carriers under fast axonal
transport (Scott et al., 2011; Tang et al., 2013). Furthermore,
by high-resolution imaging and single-particle tracking, we
identified and characterized diffusive modes of transport and
actively driven transport that mediate the distribution of
proteasomes within axons. We showed different types of fast
moving vesicles and membrane organelles that drive the active
transport of proteasomes. In addition, within our characterization,
we identified the presence of confined proteasomes that could be
interpreted as proteasomes that are trapped during a process that
might involve the specific degradation of polyubiquitinated
proteins.
Different lipid interaction experiments performed in yeast
and in vitro suggest that proteasome complexes can associate
with membranes (Kalies et al., 2005; Newman et al., 1996).
Indeed, our current findings of similar fractionation profiles for
different proteasome subunits in sucrose gradients suggest
that assembled complexes are associated with membranes. In
addition, synaptosome vesicle enrichment showed the presence of
subunits from the 20S core and the 19S regulatory lid, suggesting
that the ubiquitin-dependent 26S proteasome can associate
with synaptic vesicles. To characterize further the membrane
compartments in which proteasomes with processive trajectories
can take over the transport processes, we recorded sequential
movies in two fluorescent channels to find proteasome
trajectories that were shared with different moving cargos.
Despite the amount of diffusive proteasomes, interestingly, we
found that some processive proteasome movement was shared
with synaptic proteins, Golgi-derived APP-containing vesicles,
endolysosomal vesicles and mitochondria. From our data, we
conclude that lysosomes contribute primarily to the retrograde
transport of the proteasome from synapses to cell bodies, whereas
similar proportions of anterograde and retrograde movement
were observed during the association of proteasomes with APP,
synaptophysin or mitochondrial cargos. However, the cargo
interactions that correspond with the remaining 50% of moving
proteasomes still need to be identified to better explain the overall
proteasome flux. In contrast with the slow axonal transport rates
expected for large cytosolic protein complexes (Terada et al.,
2010), here we describe the novel and surprising finding that
the proteasome barrel is transported along axons by means of
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‘hitch-hiking’ the fast and membrane-associated axonal transport
mechanism. These results could also be interpreted as the
transport of some membranous cargos along axons requiring
co-transport with an assembled and functional proteasome
complex. The association between proteasomes and moving
cargos could be useful to degrade specific proteins during
transport or upon arrival at the destination and, therefore, be
distinct from cargos without proteasomes. The possibility that
proteasome–membrane interactions mediate fast axonal transport
of proteasomes in mobile vesicle units suggests that there is a
direct link between proteasomes and membranes that requires
further investigation. Modification of such a linker should change
the mobility and/or distribution of the proteasome complex in
polarized cells.
We have previously described that transport defects mediate
the early neuronal pathways that lead to abnormal protein
accumulation, protein deposition and enhanced axonopathies in
different mouse models of neurodegeneration (Falzone et al.,
2010; Falzone et al., 2009; Stokin et al., 2005). Similar transport
defects can be further increased by proteasome inhibition (Tai
et al., 2012; Tseng et al., 2008), which suggests that the neuronal
protein degradation pathway closely interacts with the transport
system. Taken together, our results reveal at least three different
modes of transport for the proteasome and further provide
evidence that assembled and functional proteasomes interact with
membrane cargos and molecular motors for fast axonal transport.
We propose a novel mechanism for the distribution and delivery
of the 26S proteasome to distant neuronal locations that, when
impaired, can lead to abnormal protein degradation phenotypes
that are observed in many neurodegenerative diseases. We
anticipate that these studies will facilitate our understanding of
the defects in protein degradation that might arise because of
impairments in proteasome mobilization.
MATERIALS AND METHODS
Mice
C57/BL6 mice were used to generate primary hippocampal cultures and
sciatic nerve ligations. The mice were housed in temperature- and light-
dark-controlled rooms under approved university protocols (UCSD-
IACUC; UBA-456/2010).
Vectors
To generate a4 proteasome subunit cDNA, mRNA from mouse brain
was obtained by RT-PCR using a first strand synthesis kit (Invitrogen).
The a4 subunit cDNA was amplified by using PCR with the primers
59-GCGCGATATCGCCACCATGAGCTACGACCGCGCCATCACC-39
(including EcoRV and Kozak sites) and 59-GCGCGCGGCCGCAGATG-
CTTTCTTTTGCTTCTTCTTTTC-39 (containing the NotI site). The a4
subunit sequence, without a stop codon, was subcloned in-frame with YFP
into the pcDNA3-CMV-YFP plasmid to obtain the vector pcDNA3-CMV-
a4-YFP. This vector was used to replace YFP with the mCherry
fluorescent marker fused to the a4 subunit by using a subcloning
strategy that utilized the NotI and ApaI restriction sites. pCDNA-CMV-
EB3-RFP was kindly provided by Shuo-Chien Ling (UCSD, La Jolla, CA).
pcDNA3-mCherry was provided by Nathan Shaner (UCSD, La Jolla, CA).
pSPH-GFP was a kind gift from Louis Reichardt (UCSF, San Francisco,
CA). Three shRNA–mCherry sequences against kif5b, from a kinesin
lentiviral mini-library, in a pLL3.7 GW lentiviral vector with gateway
entry modifications and an mCherry marker, were tested for reduction of
levels of the KIF5B protein (Encalada et al., 2011).
Antibodies
Monoclonal antibodies against the following proteins were used:
kinesin heavy chain (KHC-H2, Millipore), 20S proteasome subunit a5
(Biomol), tubulin (DM1a, Covance), ubiquitin (FK2, Biomol), ubiquitin
(Chemicon). Polyclonal antibodies against the following proteins were
used: proteasome a-b (pan-antibody recognizing subunits a5 or a7, and
b1, b5 and b7, Biomol), b5, Mss1, PA28a (Biomol); YFP (Molecular
Probes); APP, map2, tau, a-synuclein (Chemicon); KIF5B [provided by
Gorazd B. Stokin (UCSD, La Jolla, CA)]; GDI, SPH, synaptotagmin
(Synaptic System); dynein heavy chain, kinesin light chain 1 (Santa Cruz
Biotechnology), syntaxin 13 (Bioss) and pJNK (Cell Signaling
Technology). Secondary antibodies were: goat Alexa Fluor 568
and 488 anti-mouse or -rabbit IgG (Invitrogen). Horseradish-
peroxidase-conjugated antibodies (Jackson Laboratories) were used in
western blots.
Sciatic nerve ligation
Mouse sciatic nerves were ligated unilaterally at the hip, one or two
nodes apart, by using surgical suture under isofluorane anesthesia.
Mice were allowed to recover for 6 hours and then killed to obtain
ligated and unligated nerves. For immunohistochemistry, nerves were
embedded by using Tissue-Tek and then frozen by using a cryostat for
sectioning later. For biochemical analyses, equal lengths of proximal,
distal and unligated nerves were homogenized in sample buffer, and
equal protein amounts were analyzed by using SDS-PAGE. All
surgical procedures performed in adult C57/BL6 mice were approved
by the University of California at San Diego Animal Committee
(IACUC).
Immunofluorescent staining and quantification
Sciatic nerves were dissected and post-fixed 2 hours in 4%
paraformaldehyde in PBS. Nerves were incubated overnight in 20%
sucrose, embedded in Tissue-Tek Optimum Cutting Temperature (OCT)
medium and frozen in dry-ice-cooled methanol. Serial 15-mm cryostat
sections were cut and mounted onto coated slides (Fisher Scientific).
Sections were permeabilized and blocked with 10% goat serum, 0.1%
Triton X-100 in PBS for 30 minutes and incubated with the indicated
primary antibodies overnight at 4 C˚. Samples were then incubated
with Alexa-Fluor-conjugated secondary antibodies for 3 hours at room
temperature. Low-resolution images were acquired by using a 206 lens
(NA: 0.75) on a Nikon TE2000 microscope. Integrated fluorescence
intensity measurements were extracted from images obtained under
similar imaging conditions comparing equal areas of proximal, distal and
unligated nerves, and normalized to the staining for phosphorylated
neurofilaments. Normalized proteasome fluorescence intensity was
plotted relative to the unligated condition. High-resolution cross-section
images were observed by using a 606 or 1006 lens (NA: 1.40) on an
Olympus FV1000 confocal microscope.
Proteasome activity assay
Quantification of proteasome activity from extracts was measured by
fluorogenic peptide hydrolysis (N-succinyl–Leu-Leu-Val-Tyr–7-amino-
4-methylcoumarin, Biomol). Fluorescence measurements corresponding
to proteasome activity (l380–460) were calibrated using a range of 5
to 80 mg of total protein. Protein homogenate (40 mg) from proximal
or unligated nerves was used to evaluate proteasome-dependent
hydrolysis.
Immunoprecipitations
Controls or N2a cells transfected with pcDNA3-CMV-a4-YFP were
homogenized in binding buffer (Tris-HCl 150 mM, NaCl 50 mM, NP40
0.1%, pH 7.5 and protease inhibitors) on ice and centrifuged for
10 minutes at 12,000 g at 4 C˚. Protein content was quantified by using
2 ml of supernatant in a bicinchoninic acid assay (BCA, Pierce). 500 mg
of protein was pre-cleared with agarose beads and then incubated with
the antibody against the a-b proteasome subunits overnight at 4 C˚.
Protein-G–agarose beads that had been pre-washed overnight were
incubated with the homogenate fraction plus primary antibody in binding
buffer for 3 hours at 4 C˚. Beads were pelleted down and washed three
times for 20 minutes with binding buffer and four times with PBS. Bound
material was eluted by boiling beads in 1.56 sample buffer for
10 minutes and loaded in SDS-PAGE gel.
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Primary hippocampal cultures and N2a cells
Culture of hippocampal cells was as described previously (Falzone and
Stokin, 2012). Briefly, newborn hippocampal brain regions from C57/
BL6 mice were dissected on postnatal day 1. Hippocampi were incubated
in a 0.22-mm-filtered mixture of 45 U of papain in PBS enriched with
0.05% of DNase for 20 minutes at 37 C˚ and then triturated by gentle
pipetting in 10% fetal bovine serum (FBS) in Dulbecco’s modified
Eagle’s medium. Cells were grown in 500 mM L-glutamine and
Neurobasal medium supplemented with B27 on poly-D-lysine-coated
coverslips at 37 C˚ under 5% CO2. Neurons transfected using
Lipofectamine 2000 (Invitrogen) between days 7–10 for 16–20 hours
were used for movie acquisition. Mouse neuroblastoma N2a cells
(American Type Culture Collection) were propagated using 0.25%
trypsin and grown at 37 C˚ under 5% CO2 in Dulbecco’s minimal
essential media supplemented with 10% FBS, 1% penicillin and
streptomycin, and 1% glutamax. N2a cells were transfected using
polyethylenimine using a 2:1 ratio PEI:DNA following standard
protocols.
Movie acquisition and kymograph analysis
Imaging and kymograph analysis was as described previously (Falzone
and Stokin, 2012). Briefly, a4–YFP movement in neurons was recorded
by using an inverted epifluorescent microscope (Olympus IX81)
connected to a CCD camera (Olympus DP71/12.5 megapixels) and
driven by a dynamic positioning. Cultures were kept under a 606 lens
(NA: 1.40) at 37 C˚ using a heating stage and under 5% CO2 by using a
CO2 chamber (Olympus). At 16–20 hours after transfection, cells were
recorded. Directionality was determined by tracking axons at distance (2
fields) from cell bodies and imaging was performed away from cell
bodies and projection tips. The pCMV-EB3-RFP vector was used to
confirm plus-end-directed polymerization of the microtubules in axons
(supplementary material Fig. S2). Continuous 30-second stacks (224
frames) at 125 mseconds/frame rate (8 Hz) were collected for a4–YFP.
Sequential double-color movies were generated under green and red
filters for 15 seconds each for a4–YFP with mitotracker (Invitrogen) and
a4–YFP with lysotracker (Invitrogen), or a4–Cherry with APP–YFP and
a4–Cherry with SPH–GFP. Shared particles were identified as those
particles that moved in the green channel and continued in the red
channel and then appeared back in the green channel with the same
direction and speed. These particles were then quantified. Pixel size was
adjusted to 0.13 mm. Kymographs were plotted with Image J using the
multiple kymograph plug-in, and average net velocities, distance and
directionality were extracted for analyses. High-resolution movies were
recorded using a 1006 lens (NA: 1.40) and a CMOS camera (Hamamatsu
ORCA/Flash 2.8 megapixels) driven by HCImage controller (Hamamatsu
Photonics, Japan). Continuous 10-second stacks (500 frames) at a rate of
20 mseconds/frame (50 Hz) were collected for a4–YFP. Pixel size was
adjusted to 0.143 mm. Kymographs were plotted with ImageJ using the
multiple kymograph plug-in and processed using MATLAB routines
(The Mathworks, Natick, MA).
High spatio-temporal tracking and analysis of trajectories
A tracking algorithm was developed to recover trajectories of fluorescent
proteasomes with a robust signal-to-noise ratio of .4 from kymographs
with an error ,20 nm. A rectangular region of interest (ROI) was
selected, which could contain more than one particle. After that, the
algorithm analyzes the first line of ROI within the kymograph,
corresponding to the intensity profile along the axon, and searches for
the maximum of intensity of the profile using a neural network
smoothing procedure. The algorithm then goes to the next line of the
ROI and searches the for the new maximum nearby. This procedure
continues until the entire ROI is analyzed. The coordinates of the particle
are recovered with subpixel resolution. In cases where the tracking was
lost owing to crowding or enhanced background noise, the tracking was
discarded. For each recovered trajectory, the mean square displacement
(MSD) was calculated as follows:
MSD tð Þ~S x tð Þ{x tztð Þð Þ2T, ð1Þ
where x is the coordinate of the proteasome along the axon, t and t are the
absolute and lag times, respectively, and the brackets represent the time
average. This calculation was performed for t ,10% of the total time of
the trajectory (Saxton and Jacobson, 1997). The MSD data were fitted
with an anomalous diffusion model:
MSD~AtazB, ð2Þ
where A depends on the motion properties of the particle and B is the
residual MSD (Brunstein et al., 2009; Nelson et al., 2009). The
exponent a can take values between 0 and 2 (Brangwynne et al., 2009;
Bruno et al., 2009). Trajectories were classified as actively driven
(a.1.5), diffusive (0.9,a,1.1) or confined (a,0.5) depending on the
value of the exponent obtained from the fitting of Eqn 2 to the MSD
data. Trajectories with a values that did not fulfill these criteria were
discarded. Segmental velocities were determined from actively driven
trajectories that were further divided into segments of 20 points. A
linear regression of the position versus time plot was performed, and
the segmental velocity was computed from the slope and included
if the value r2.0.75 (Levi et al., 2006). The diffusion coefficient (D)
for the proteasome was obtained from diffusive trajectories with
MSDs scaling to a lineal regression considering the slope equal
to 2DC. Theoretical D in water was calculated by: D5kT/6phr,
considering the proteasome radius as 14.72 nm (Bohn et al., 2010).
The size of the region of confinement (Rc) was determined as:
Rc~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SMSD(tp)T{MSD(0)
p
where SMSD(tp)T is the value of the
MSD averaged for all times tp belonging to the plateau and MSD(0) is
the value of the MSD for t?0.
Synaptosomes
Purification of synaptosomes has been described previously (Abe et al.,
2009). Briefly, homogenized mouse brain cortices treated at 4 C˚
(0.3 M sucrose, 4 mM HEPES pH 7.5 and protease inhibitors) were
centrifuged for 10 minutes, 800 g, to obtain a P1 pellet and S1
supernatant. P2 and S2 were obtained by centrifuging S1 for
15 minutes at 9200 g. A similar procedure was repeated to obtain
P29 which was then subjected to hypotonic shock with nine volumes of
cold water. The solution was exchanged into 4 mM HEPES pH 7.5.
Synaptic vesicle (LS1) and plasma membrane (LP1) fractions were
obtained by centrifugation, 20 minutes at 25,000 g. The synaptosome
fraction (LP2) was obtained by sedimenting LS1 on a 38% sucrose
cushion, 2 hours at 165,000 g.
Sucrose density gradient
Briefly, cells harvested in cold PBS with protease inhibitor were
centrifuged for 5 minutes at 2000 g at 4 C˚. The pellets were re-suspended
with a Teflon glass potter in sucrose buffer (8% sucrose, 4 mM
HEPES, EDTA 2 mM, EGTA 2 mM pH 7.5 and protease inhibitors) and
centrifuged for 10 minutes at 12,000 g. The supernatant was mixed with
an equal volume of 62% sucrose buffer and was then bottom loaded, and
2.5 ml of 35%, 25% and 8% sucrose were sequentially added.
Continuous gradients were generated by centrifugation for 16 hours at
100,000 g at 4 C˚. Fractions of 1 ml were methanol and chloroform
precipitated and re-suspended in sample buffer.
Particle density distribution function analysis for confined
trajectories
Particle density distribution function (PDDF) distinguished three different
models of confinement: (1) a harmonic potential U(r)5Uo r2, where
particles are bound by a spring-like force-producing mechanism;
(2) a cone potential U(r)5Uo r, where particles are trapped by a
softer potential than that of the harmonic one; and (3) a r4 potential
U(r)5Uo r4, which is harder than the spring potential where U(r) is
the potential function, r the radius from the potential origin and Uo
the potential strength. Thus, the normalized PDDF is given by:
PDDF(r)/PDDF(0)5e2U(r)/KBt where KB is the Boltzmann constant
and t is the absolute temperature. The PDDF was calculated for the
position data as: PDDF(x)5N(x)/Dx where Dx is the distribution
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resolution and N(xo) is the number of events. Distribution was
normalized by PDDF(0) for nonlinear least squares regression of
Boltzmann distribution functions.
Statistical analysis
Values are expressed as means6standard error of the mean (s.e.m.) for
the indicated number of independent experiments or corresponding
particles (n). The normal distribution of the samples was assessed prior
to analysis of significance. A two-tailed Student’s t-test was used to
compare differences between groups. A nonparametric Mann–Witney
test was used when samples did not reach normality. Statistical analyses
were performed using Graph-pad or MATLAB software.
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